date:Aug 05, 2014
its likely utility in treating patients.
Published research has demonstrated that nicotinamide riboside can play an important role in NAD+ production, which is an important cellular co-factor in mitochondrial health, said Frank Jaksch, Jr., founder and CEO of ChromaDex. Researchers worldwide are working to build on this research and investigate NR's efficacy in therapeutic applications, and we are happy to support Dr. Thorburn's important research on pediatric mitochondrial disorders. Further,